NCT07161479View on ClinicalTrials.gov

Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma

NANot yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

October 31, 2026

Conditions
Gastric AdenomaStomach NeoplasmsPrecancerous ConditionsDysplasia Stomach
Interventions
PROCEDURE

Argon Plasma Coagulation (APC)

Ablation of gastric adenoma using argon plasma coagulation.

PROCEDURE

Endoscopic Mucosal Resection (EMR)

Endoscopic resection of gastric adenoma by mucosal resection technique.

Trial Locations (3)

10408

National Cancer Center, Goyang-si

03181

Kangbuk Samsung hospital, Seoul

06351

Samsung Medical Center, Seoul

All Listed Sponsors
collaborator

Samsung Medical Center, Sungkyunkwan University School of Medicine

UNKNOWN

lead

Samsung Medical Center

OTHER

NCT07161479 - Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma | Biotech Hunter | Biotech Hunter